MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
2.220
-0.090 (-3.90%)
Nov 5, 2026, 4:00 PM EST - Market closed
MacroGenics Market Cap
MacroGenics has a market cap or net worth of $141.41 million as of November 5, 2026. It is the 22,480th most valuable company in the world and the 3,800th biggest in the United States. Its market cap has increased by 54.38% in one year.
Market Cap
141.41M
Enterprise Value
3.20M
1-Year Change
54.38%
Global Rank
Country Rank
#3,800 United States
Category
ChartMarket Cap Chart
Since October 10, 2013, MacroGenics's market cap has decreased from $600.30M to $141.41M, a decrease of -76.44%. That is a compound annual growth rate of -10.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 141.41M | 38.91% |
| Dec 31, 2025 | 101.80M | -50.10% |
| Dec 31, 2024 | 204.00M | -65.81% |
| Dec 29, 2023 | 596.70M | 44.65% |
| Dec 30, 2022 | 412.50M | -58.05% |
| Dec 31, 2021 | 983.20M | -23.47% |
| Dec 31, 2020 | 1.28B | 141.41% |
| Dec 31, 2019 | 532.20M | -0.84% |
| Dec 31, 2018 | 536.70M | -23.28% |
| Dec 29, 2017 | 699.60M | -1.74% |
| Dec 30, 2016 | 712.00M | -33.00% |
| Dec 31, 2015 | 1.06B | 9.02% |
| Dec 31, 2014 | 974.80M | 42.04% |
| Dec 31, 2013 | 686.30M | 14.33% |
| Oct 10, 2013 | 600.30M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Canton Strategic Holdings | 162.55M |
| Adagene | 153.76M |
| Sutro Biopharma | 151.05M |
| Atrium Therapeutics | 146.25M |
| Veraxa Biotech AG | 145.65M |
| NervGen Pharma | 145.16M |
| Protara Therapeutics | 142.42M |
| Cue Biopharma | 141.07M |